CCM
FLXN

Campbell Capital Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Campbell Capital Management’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-15,500
Closed -$321K – 60
2019
Q4 		$321K Sell
15,500
-115,122
-88% -$1.94M 0.2% 48
2019
Q3 		$1.79M Buy
130,622
+1,000
+0.8% +$11.9K 1.33% 22
2019
Q2 		$1.59M Buy
+129,622
New +$1.5M 1.27% 21

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Campbell Capital Management's FLXN Position: Q1 2020 in Review

Campbell Capital Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q1 2020, closing a stake of 15,500 shares — an estimated $321K sold.

Campbell Capital Management first reported a position in FLXN in Q2 2019 and held it in 3 quarters. The position peaked at $1.79M in Q3 2019. 123 funds tracked by Wall St. Rank hold FLXN as of Q1 2020.

  • Campbell Capital Management reported no remaining Flexion Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
  • Campbell Capital Management sold 15,500 Flexion Therapeutics, Inc. shares in Q1 2020, an estimated $321K.
  • Campbell Capital Management first reported a position in Flexion Therapeutics, Inc. in Q2 2019 and held it in 3 quarters.
  • Campbell Capital Management's Flexion Therapeutics, Inc. position peaked at $1.79M in Q3 2019.
  • 123 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q1 2020.

Based on Campbell Capital Management's 13F filing for Q1 2020, filed 10 Apr 2020.